Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    12540794 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil
Condition: HepatoCellular Carcinoma
Intervention: Drug: 5-Fu, oxaliplatin , leucovorin
2 Recruiting Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib;   Procedure: Hepatic arterial infusion chemotherapy;   Drug: Folfox Protocol
3 Completed Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Procedure: Transarterial chemoembolization (TACE)
4 Unknown  Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Hepatectomy;   Procedure: TACE combined with local regional therapies without hepatectomy
5 Recruiting Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Transarterial Radioembolization;   Procedure: Transarterial Chemoembolization using drug-eluting beads
6 Active, not recruiting TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
7 Recruiting Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
Condition: Liver Cancer
Intervention: Procedure: Blood draw

Study has passed its completion date and status has not been verified in more than two years.